Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

BACKGROUND: Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. OBJECTIVE: We set-up a multicenter Italian collaboration to investigate the relationship between HCQ therapy and COVID-19 in-hospital mortality. METHODS: In a retrospective observational study, 3,451 unselected pa...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446618/
https://www.ncbi.nlm.nih.gov/pubmed/32859477
http://dx.doi.org/10.1016/j.ejim.2020.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446618/
https://www.ncbi.nlm.nih.gov/pubmed/32859477
http://dx.doi.org/10.1016/j.ejim.2020.08.019

Ejemplares similares